Eva Surmacz

Title: Eva Surmacz: Innovator in Pharmaceutical Agonists

Introduction

Eva Surmacz is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors involved in various diseases. With a total of 3 patents, her work is paving the way for innovative treatments in cellular proliferative disorders.

Latest Patents

Surmacz's latest patents include groundbreaking inventions such as "Adiponectin receptor agonists and methods of use." This patent focuses on short peptide mimetics of adiponectin, which are suitable for development as pharmaceutical agonists in treating cellular proliferative disorders like cancer and atherosclerosis. Another notable patent is the "Leptin antagonist and methods of use." This invention provides compounds that act as true antagonists of the leptin receptor, which can inhibit leptin receptor activity and promote the growth arrest or death of leptin receptor-positive cancer cells. These compounds have potential applications in treating various conditions, including weight-loss nutritional disorders, osteoporosis, rheumatoid arthritis, osteoarthritis, and inflammatory bowel disease.

Career Highlights

Eva Surmacz is affiliated with Temple University, where she continues her research and development in the pharmaceutical field. Her work has garnered attention for its potential impact on treating serious health conditions.

Collaborations

One of her notable collaborators is Laszlo Otvos, with whom she has worked on various projects related to her patents.

Conclusion

Eva Surmacz is a trailblazer in the pharmaceutical industry, with her innovative patents addressing critical health issues. Her contributions are essential in the ongoing quest for effective treatments for complex diseases.